# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA615651 | F | In vivo anti-tumor and anti-metastatic activity was measured after oral dosing 15 mg/kg b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor | Mus musculus | 5 | ALA1135068 | organism-based format | Scientific Literature | |
2. | ALA615652 | F | In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor | Mus musculus | 1 | ALA1135068 | organism-based format | Scientific Literature | |
3. | ALA615653 | F | In vivo anti-tumor and anti-metastatic activity following p.o. administration b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor; Not tested. | Mus musculus | 20 | ALA1135068 | organism-based format | Scientific Literature | |
4. | ALA615654 | F | accumulation of compound in 3LL cells was measured with DFMO by HPLC at 1 uM dose | Mus musculus | 1 | ALA1134661 | cell-based format | Scientific Literature | |
5. | ALA615655 | F | accumulation of compound in 3LL cells was measured with DFMO by HPLC at 10 uM dose | Mus musculus | 3 | ALA1134661 | cell-based format | Scientific Literature | |
6. | ALA825024 | F | accumulation of compound in 3LL cells was measured with DFMO by HPLC at 250 uM dose | Mus musculus | 3 | ALA1134661 | cell-based format | Scientific Literature | |
7. | ALA615656 | F | accumulation of compound in 3LL cells was measured with DFMO by HPLC at 50 uM dose | Mus musculus | 6 | ALA1134661 | cell-based format | Scientific Literature | |
8. | ALA615657 | F | accumulation of compound in 3LL cells was measured with DFMO by ICP-AES at 50 uM dose | Mus musculus | 3 | ALA1134661 | cell-based format | Scientific Literature | |
9. | ALA615658 | F | accumulation of compound in 3LL cells was measured without DFMO by HPLC at 1 uM dose | Mus musculus | 1 | ALA1134661 | cell-based format | Scientific Literature | |
10. | ALA615659 | F | accumulation of compound in 3LL cells was measured without DFMO by HPLC at 10 uM dose | Mus musculus | 4 | ALA1134661 | cell-based format | Scientific Literature | |
11. | ALA615660 | F | accumulation of compound in 3LL cells was measured without DFMO by HPLC at 250 uM dose | Mus musculus | 3 | ALA1134661 | cell-based format | Scientific Literature | |
12. | ALA615661 | F | accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose | Mus musculus | 5 | ALA1134661 | cell-based format | Scientific Literature | |
13. | ALA615662 | F | accumulation of compound in 3LL cells was measured without DFMO by ICP-AES at 50 uM dose | Mus musculus | 5 | ALA1134661 | cell-based format | Scientific Literature | |
14. | ALA615663 | F | Effect on the growth of 3LL cells by DFMO pretreatment at 48 hr incubation | Mus musculus | 8 | ALA1134661 | cell-based format | Scientific Literature | |
15. | ALA615664 | F | Effect on the growth of 3LL cells was evaluated using an MTT assay at 48 hour incubation | Mus musculus | 11 | ALA1134661 | cell-based format | Scientific Literature | |
16. | ALA615665 | F | Effect on the growth of 3LL cells was evaluated using an MTT assay at 72 hour incubation | Mus musculus | 11 | ALA1134661 | cell-based format | Scientific Literature | |
17. | ALA615666 | F | accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose | Mus musculus | 1 | ALA1134661 | cell-based format | Scientific Literature | |
18. | ALA615667 | F | putrescine levels in 3LL cells after the treatment of 1 uM of Compound | Mus musculus | 1 | ALA1134661 | cell-based format | Scientific Literature | |
19. | ALA615668 | F | putrescine levels in 3LL cells after the treatment of 10 uM of Compound | Mus musculus | 1 | ALA1134661 | cell-based format | Scientific Literature | |
20. | ALA615669 | F | putrescine levels in 3LL cells after the treatment of 250 uM of Compound | Mus musculus | 2 | ALA1134661 | cell-based format | Scientific Literature |